Physician profile
John Liu
NPI 1457732661
$2,156.00
in general payments reported to CMS, 2019-2025
12 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2022: $44.32 · 2023: $1,566 · 2024: $145 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,290 · Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,290.00 |
| Food and Beverage | $710.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,399.97 | 2023 | Iaccess Precision Blade, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is |
| Alcon Vision LLC | $243.77 | 2023-2025 | Tryptyr, Hydrus Microstent, Rocklatan |
| Shire North American Group INC | $111.54 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $88.77 | 2022-2023 | Tecnis Iol |
| Viiv Healthcare Company | $83.28 | 2024 | Dovato, Cabenuva |
| Sight Sciences, INC. | $46.21 | 2023-2024 | Omni Surgical System |
| Bayer Healthcare Pharmaceuticals INC. | $45.79 | 2023-2024 | |
| Bausch & Lomb Americas INC. | $37.07 | 2024-2025 | Miebo, Xiidra |
| Regeneron Healthcare Solutions, INC. | $34.53 | 2025 | Libtayo |
| Abbvie INC. | $28.06 | 2023 | |
| Sun Pharmaceutical Industries INC. | $19.00 | 2023 | Cequa |
| New World Medical,INC. | $18.01 | 2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Via360 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.